Noom Med
Status: Unpriced · 3 row(s) on file · checked 2026-09-17
A data file, not a finished review: the prices below are third-party Reported figures with their source and check date. They move to First-party only after our own dated walk of Noom Med's pages — and this page will say so when they do.
Reported pricing on file · semaglutide, tirzepatide
- Semaglutide (microdose)
- from $179/mo — 3-mo plan; payment basis not printed; $0 membership
- Provenance
- noom.com · checked 2026-09-17
Provider scorecard — the fields the sprint fills
| Pharmacy on file | not yet on file — queued |
| Pharmacy type | queued |
| States served | queued — unconfirmed coverage keeps state pages noindexed |
| Membership · consult fee | $0 · $0 |
| Dose-change policy | not stated |
| Cancellation terms | queued |
| Shipping | queued |
| Intro price (first month/period) | — |
| Medication included in price | yes |
| Offer conditions on file | — |
| Offer expiry / scheduled recheck | — |
| Support-response test | pending — standardized three-question timed email test, per the sprint |
| Cancellation walkthrough | pending — scripted cancel-and-document test, per the sprint |
| Update history | row verified/recorded 2026-09-17 · file regenerated 2026-09-20 |
Watch-outs recorded by trackers
- Microdose GLP-1Rx page read 2026-09-17: 'Plans start at $79 and include medication' — the $79 buys an initial three-week subscription with four weeks of medication, then '$179 per month plus tax for 12 week subscription thereafter'; medication, clinical visits and program access included; 'Cancel anytime'; compounded semaglutide 'produced in an FDA-registered facility but has not been reviewed by the FDA'; 'New pricing for new accounts only effective as of July 27, 2026'; the Noom Med hub also prints brand-name access 'starting at $39' and a meta description 'Starting at $149' for its standard program, neither with a plan printed.
- Read 2026-09-17: no tirzepatide price is printed on the pages read; brand-name access 'starting at $39' and a microdose semaglutide program from $79 are the only figures.
- Read 2026-09-17: the Noom Med hub prints brand-name access 'starting at $39' and a meta description 'Starting at $149' for its standard compounded program, neither with a plan in the page body; only the Microdose GLP-1Rx program is priced on its own page ($79 to start, then $179 a month on 12-week subscriptions — see the microdose rows).
What we have not verified
The standing (non-promo) rate at every dose; whether the figure is all-inclusive; the dispensing pharmacy and its 503A/503B status; state availability; cancellation terms. Until those are recorded first-party, Noom Med appears in ranked tables at its reported figure with a Reported chip, never a Verified one — the same rule applied to every program here, including every partner program — placements are labeled “Editor’s Pick” and disclosed.
No outbound link: we have not confirmed this program's canonical domain first-party, and we do not guess URLs.